95 results on '"Maleki I"'
Search Results
2. Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Lymphocyte to Monocyte Ratio in Gastric Cancer Patients Compared with the Control Group and Its Association with Pathological Factors of the Disease.
- Author
-
Maleki, I., Eslami-Jouybari, M., Memari, H., Hedayatizadeh-Omran, A., Asgarian-Omran, H., and Alizadeh-Navaei, R.
- Abstract
Background and Objective: Considering the prevalence of gastrointestinal cancers in the region and the importance of helpful criteria in the diagnosis of the disease, the present study was conducted to compare the blood parameters neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and lymphocyte to monocyte ratio (LMR) in gastric cancer patients in Mazandaran province and its comparison with non-affected people. Methods: This cross-sectional study was conducted in 2019 and 2020 on 62 cancer patients referred to Imam Hospital in Sari in the case group and 124 non-patients from the community in the control group. Convenience sampling was used in the case group and random sampling was used in the control group from among the Tabari Cohort Population. The two groups were matched in terms of age and gender. The required data including age, gender, LMR, NLR and PLR for all subjects as well as pathological indices and chemotherapy status were recorded for the case group. Findings: The gender ratio in both groups was 69.4% males and 30.6% females. The mean age of the examined subjects in the group of cancer patients and the control group was 62.3±12.53 and 51.7±9.02 years, respectively (p=0.105). The mean NLR (2.14 vs. 1.62, p=0.000) and PLR (9.48 vs. 6.27, p=0.000) in the group with gastric cancer were significantly higher than the healthy control group, and the mean LMR (3.42±2.12 vs. 10.9±2.99, p=0.000) was significantly lower than the healthy control group. Conclusion: The results of high NLR and PLR and low LMR showed that these indices can be used in gastric cancer screening studies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
3. New class of hybrid explicit methods for numerical solution of optimal control problems.
- Author
-
Ebadi, M., Maleki, I. Malih, and Ebadian, A.
- Subjects
FORWARD-backward algorithm ,FAST sweeping methods (Mathematics) ,NUMERICAL solutions to differential equations ,PONTRYAGIN'S minimum principle ,LAGRANGE equations - Abstract
Forward-backward sweep method (FBSM) is an indirect numerical method used for solving optimal control problems, in which the differential equation arising from this method is solved by the Pontryagin's maximum principle. In this paper, a set of hybrid methods based on explicit 6th-order Runge-Kutta method is presented for the FBSM solution of optimal control problems. Order of truncation error, stability region, and numerical results of the new hybrid methods were compared with those of the 6th-order Runge-Kutta method. Numerical results show that new hybrid methods are more accurate than the 6th-order Runge-Kutta method and that their stability regions are also wider than that of the 6th-order Runge-Kutta method. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. EVALUATION OF THE COMBINED EFFECTS OF SPLIT VS. DAY BEFORE AND LOW RESIDUE VS. CLEAR FLUID REGIMENS ON THE COLONOSCOPY PREPARATION
- Author
-
Bari, Z, additional, Maleki, I, additional, Hadizadeh, M, additional, Fakheri, H, additional, Valizadeh, SM, additional, Hoseini, V, additional, Taghvaei, T, additional, and Kazemi, A, additional
- Published
- 2019
- Full Text
- View/download PDF
5. P742 Iranian Registry of Crohn’s and Colitis (IRCC): first nation-wide IBD registry in Middle East, a study protocol
- Author
-
Malekzadeh, M, primary, Sima, A, additional, Alatab, S, additional, Sadeghi, A, additional, Ebrahimi Daryani, N, additional, Adibi, P, additional, Maleki, I, additional, Vossoughinia, H, additional, Fakheri, H, additional, Yazdanbod, A, additional, Taghavi, S A, additional, Aghazadeh, R, additional, Somi, M H, additional, Zendehdel, K, additional, Vahedi, H, additional, and Malekzadeh, R, additional
- Published
- 2019
- Full Text
- View/download PDF
6. A closed-form solution for the bending analysis of composite sandwich pipe with compliance core based on high-order sandwich theory.
- Author
-
Maleki, I and Rahmani, O
- Subjects
- *
FLEXIBLE structures , *FINITE element method , *VARIATIONAL principles , *SANDWICH construction (Materials) , *STRUCTURAL analysis (Engineering) , *PIPE - Abstract
In this paper, bending of cylindrical sandwich pipes based on the high-order theory of sandwich structures with flexible core is investigated. The cylindrical sandwich pipe is composed of a flexible core and two composite face sheets. Behavior of the cylindrical sandwich pipe is described by a high-order sandwich shell theory, which explains nonlinear distortions of cross-sectional plane of the flexible core as well as changes in its height. The theory based on variational principles and using an extremely thorough systematic closed-form approach is formulated. In this model, no assumption has been considered for displacement distribution of core components. In this study, stress and displacement of the flexible core are obtained through a three-dimensional elasticity solution and the face sheets are modeled using classical shell theory. Also, a comparison is made in order to verify high-order solution results between a closed-form solution, which is expanded for simply supported boundary conditions and results that are obtained from the commercial finite element method. Finally, influences of physical and geometrical parameters on behavior of the cylindrical sandwich pipe are investigated. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease.
- Author
-
Dabiri, R., Mahmoudi, T., Sabzikarian, M., Asadi, A., Farahani, H., Nobakht, H., Maleki, I., Mansour-Ghanaei, F., Derakhshan, F., and Zali, M. R.
- Published
- 2020
8. A closed-form solution for the bending analysis of composite sandwich pipe with compliance core based on high-order sandwich theory
- Author
-
Maleki, I, primary and Rahmani, O, additional
- Published
- 2018
- Full Text
- View/download PDF
9. An Analytical Study of the Effect of Fluid Flow on Damping Characteristics in Deep Drilling
- Author
-
Maleki, I., Nouri, N. M., Madoliat, R., Maleki, I., Nouri, N. M., and Madoliat, R.
- Abstract
In this study a new method for suppression of chatter vibration in deep drilling based on the model previously provided by authors [Mehrabadi et al., International Journal of Machine Tools and Manufacture 49.12 (2009): 939-946] is discussed. The study showed that the application of the fluid flow would improve the damping characteristic of the drill bit. Some of the advantages of this method are: (i) being simple and low cost in construction, (ii) easy to assemble, and (iii) elimination of the need to adjust damping characteristic of the suppression method. In this research investigation, it is shown that by introducing a Stokes flow around the drill bit contained in a jacket, asymptotic border line of stability could be raised drastically while frequency of the chatter does not vary dramatically.
- Published
- 2017
10. Investigating the Effect of Fluid Flow on Chatter Vibration in Drilling
- Author
-
Maleki, I. and Maleki, I.
- Abstract
In this work the effect of fluid flow on damping characteristics in deep drilling is investigated. Chatter suppression could be performed by both active and passive methods. Generally, passive methods are less costly; however, they require modifications in tool and machine design and structure before the operation; hence, they may not be suitable for currently running equipment. On the other hand, inducting fluid flow as a damping tool does not require any changes in the machine tool structure and could be applied only by adding an extra part (e.g. a cylinder around the drill bit as a fluid container) to the cutting setup. This container could be a flexible cylinder or a multi sliding part cylinder which surrounds the drill bit and the damping fluid and helps to suppress the chatter vibration. In this study, it was shown that conventional cutting fluids could be used as the damping agents; in fact, they could drastically improve damping characteristics of the cutting process. It was also shown that the gap between the drill bit and the cylinder does not have to be precise which lead to even cheaper construction costs. In other words, the asymptotic border of stability (ABL) would drastically rise by adding a cylinder with one to two millimeter gap around the drill bit and forcing the cutting fluid to pass through this gap.
- Published
- 2017
11. Urinary tract infection among intellectual disability individuals ?Etiology and antibiotic resistance patterns? in rehabilitation centers of Mazandaran province, Northern Iran
- Author
-
Nasrolahei, M, Poorhagibagher, M, Vahedi, M, Maleki, I, Nasrolahei, M, Poorhagibagher, M, Vahedi, M, and Maleki, I
- Abstract
Objective. Urinary tract infections (UTIs) are amongst the most common infections and account for large proportion of antibacte- rial drug consumption. The aim of this study was to determine the rate and the etiologic agents of UTIs in inhabitants of rehabili- tation centers of Mazandaran province in northern Iran and to evaluate the antimicrobial susceptibility patterns of the uropatho- gens isolated. Methods. Clean catch midstream urine sample was collected from each of 314 participants (163 males, 151 females) residing in 12 rehabilitation centers of Ramsar, Nowshahr, Chalous, Amol, Sari and Behshahr. Urine specimens were cultured and bacterial iso- lates were identified by conventional methods. All urines fulfilling the criteria for the presence of significant bacteriuria (?104 cfu / ml urine) were defined as positive. Antibiotic susceptibility testing was performed by Kirby-Bauer disc diffusion method. Results. The rate of urinary tract infection was 30.9% with the highest rate in pediatrics (p inf. 0.0001).The prevalence of UTIs were shown to be higher in females than in males with the rate of 46.3% in young aged females (20-29 years), 60% in middle aged group (40-49 years) and 50% in elderly (> 50 years). Bacteria most frequently isolated from urine specimens was Escherichia coli (39.2%) with the highest rate of infection in females age group inf. 10 years (p inf. 0.001). Among the antibiotics tested against the isolated organisms for susceptibility test, ceftriaxone and gentamicin main- tain good activity against the majority of gram negative bacteria that cause UTIs recovered from individuals with intellectual dis- ability. Vancomycin was effective against Staphylococcus aureus. Conclusions. This survey shows that the prevalence of UTIs among inhabitants of institutions for mentally retarded persons in Mazandaran province of Iran is much higher than normal population.
- Published
- 2013
12. Incidence of Vertebral Hemangioma on Spinal Magnetic Resonance Imaging in Northern Iran
- Author
-
Barzin, M., primary and Maleki, I., additional
- Published
- 2009
- Full Text
- View/download PDF
13. High sensitive CRP and pentraxine 3 as noninvasive biomarkers of nonalcoholic fatty liver disease.
- Author
-
MALEKI, I., RASTGAR, A., HOSSEINI, V., TAGHVAEI, T., RAFIEI, A., BARZIN, M., TORABIZADEH, Z., NAGHSHVAR, F., and KHALILIAN, A.
- Abstract
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) has become the most common hepatic disease. Liver biopsy is the gold standard for the diagnosis of NAFLD. To overcome the problems with liver biopsy many studies are being performed to find noninvasive methods for the evaluation of hepatic status. AIM: This study aims to study to role of high sensitive CRP and pentraxine 3 in the setting of NAFLD PATIENTS AND METHODS: thirty two NAFLD cases and 34 controls were enrolled. All subjects were studied clinically and blood was drawn for para-clinical studies. Liver biopsy was performed for all cases. Levels of hs-CRP and pentraxine were analyzed to find any significant difference for the stages of steatosis and fibrosis based on pathologic findings. RESULTS: Hs-CRP level was higher in nonalcoholic steatohepatitis (NASH) cases versus non-NASH cases. Its level was also increased in higher levels of fibrosis. Pentraxine 3 had no efficacy in differentiating different levels of NAFLD and fibrosis. CONCLUSIONS: Hs-CRP can be used in combination with other biomarkers in the noninvasive evaluation of NAFLD. [ABSTRACT FROM AUTHOR]
- Published
- 2014
14. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn’s disease
- Author
-
Khalili Ali, Ebrahimpour Soheil, Maleki Iradj, Abediankenari Saeid, and Afrouzi Mousa Mohammadnia
- Subjects
crohn’s disease ,regulatory t cells ,il-10 ,il-35 ,Internal medicine ,RC31-1245 - Abstract
Background. Regulatory T (Treg) cell plays a key role in autoimmune diseases. We evaluated the regulatory function and frequency of Treg cells and secreted IL-10, IL-35 concentration in Crohn’s disease (CD).
- Published
- 2018
- Full Text
- View/download PDF
15. Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
- Author
-
Mokhtare, M., Hosseini, V., Fakheri, H. T., Maleki, I., Taghvaei, T., Valizadeh, S. M., Sardarian, H., Shahram Agah, and Khalilian, A.
16. Comparison of meperidine-midazolam and propofol-fentanil sedation in patients scheduled for elective colonoscopy
- Author
-
Hosseini, V., Fakheri, H., Zamani, A., Shoopay-Juybari, A., Nadia Banihashem, Maleki, I., and Taghvaei, T.
17. Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease
- Author
-
Ardakani, M. J. E., Aghajanian, M., Nasiri, A. A., Hamid Mohaghegh Shalmani, Zojaji, H., and Maleki, I.
- Subjects
Dictation ,Helicobacter pylori ,Original Article ,Triple therapy regimens - Abstract
Aim: The aim of this study was to compare the half-dose and full-dose triple therapy regimens for Helicobacter pylori (Hp) eradication in patients with end-stage renal disease. Background: H. Pylori is one the most important causes of dyspepsia in patients with end-stage renal disease (ESRD). Patients and methods: Sixty-six patients with ESRD were enrolled in the study with Hp infection and peptic disease with a need of Hp eradication. Patients were randomly assigned to full-dose (A=35 patients) or half-dose group (B=31 patients). Patients received clarithromycin 500 mg, amoxicillin 1000 mg and omeprazole 20 mg twice daily in group A and clarithromycin 250 mg and amoxicillin 500 mg twice daily and omeprazole 20 mg once daily in group B for two weeks. Patients provided stool samples 4 weeks of completing study to assess the success of Hp eradication by Hp-specific stool antigen. Finally, the rate of eradication and complications were compared between two groups. Results: The successful Hp eradication was achieved in 26 patients (74%) in group A and in 22 patients (74%) in group B. The difference between 2 groups was not statistically significant (p=0.973) (per protocol analysis). Conclusion: Half-dose triple-therapy with clarithromycin, amoxicillin and omeprazole is as effective as full-dose triple-therapy to eradicate the Hp in patients with ESRD. According to lower toxicity level, complications and cost in half-dose regimen in this subset of patients, this protocol is advised.
18. A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease
- Author
-
Dabiri, R., Touraj Mahmoudi, Sabzikarian, M., Asadi, A., Farahani, H., Nobakht, H., Maleki, I., Mansour-Ghanaei, F., Derakhshan, F., and Zali, M. R.
- Subjects
Non-alcoholic Fatty Liver Disease ,Case-Control Studies ,Insulin Receptor Substrate Proteins ,Humans ,Insulin ,3' Untranslated Regions - Abstract
Nonalcoholic fatty liver disease (NAFLD) is an increasing global health concern defined by excessive hepatic fat content in the absence of excessive alcohol consumption. Regarding the key role of insulin and insulin resistance in NAFLD, we investigated whether insulin receptor substrate 1 (IRS1) and insulin receptor substrate 2 (IRS2) gene variants were associated with NAFLD risk.In this case-control study, 305 subjects including 151 cases with biopsy-proven NAFLD and 154 controls were enrolled. All the subjects were genotyped for IRS1 (rs1801278) and IRS2 (rs2289046) gene variants using PCR-RFLP method.Our findings showed that the IRS2 rs2289046 "GG+AG" genotype compared with "AA" genotype to be a marker of decreased NAFLD susceptibility and the difference remained significant even after adjustment for confounding factors including age, BMI, sex, smoking status, systolic blood pressure, and diastolic blood pressure (P=0.014; OR=0.50, 95%CI= 0.29-0.87). Furthermore, the IRS2 "G" allele was significantly underrepresented in the cases with NAFLD than controls (P=0.026 ; OR=0.62, 95%CI=0.41-0.94). However, no significant difference was found for IRS1 rs1801278 gene variant.This study suggests, for the first time, that the IRS2 gene rs2289046 variant may play a role in NAFLD susceptibility. Nevertheless, this observation warrants further investigations in other populations.
19. Calprotectin: A promising non-invasive tool for ulcerative colitis monitoring
- Author
-
Hassan Neishaboori, Taghvaei, T., Maleki, I., Nagshvar, F., Fakheri, H., Hosseini, V., and Mohammad Valizadeh, S.
20. Short term effects of ginger on quality of life, disease activity index, inflammatory and oxidative stress factors in ulcerative colitis
- Author
-
Bodaghi, M. N., Maleki, I., Agah, S., and Azita Hekmatdoost
- Subjects
lcsh:R5-920 ,ginger ,inflammation ,oxidative stress ,lcsh:Medicine (General) ,ulcerative colitis - Abstract
Background: Chronic inflammation and oxidative stress are the two essential factors determining ulcerative colitis (UC) onset and severity status. In present study, we aimed to investigate short-term effects of ginger (Zingiber officinale) as a well-known antioxidant and anti-inflammatory agent on the quality of life, disease activity index and some of inflammatory and oxidative stress factors in patients with active mild to moderate UC. Methods: This study was a double blind placebo controlled randomized clinical trial conducted in nutrition and diet therapy clinic of Shahid Beheshti University of Medical Science, Tehran, Iran, from October 2017 to June 2018. Forty-six patients with active mild to moderate UC daily consumed four capsules of 500 mg dried ginger powder or similar placebo through eating their meals for 6 weeks. Before and after intervention, we analyzed patient´s scores of disease activity index, by simple clinical colitis activity index questionnaire (SCCAIQ) as well as their quality of life using inflammatory bowel disease questionnaire-9 (IBDQ-9). We also measured serum concentrations of total antioxidant capacity (TAC), malondialdehyde (MDA), tumor necrosis factor (TNF-α), high sensitive (hs)-CRP and nuclear factor κB (NF-κB) in fasted blood samples of each participant. Additionally, anthropometric and dietary intake values of energy, macro/micronutrients and minerals of all of participants were assessed at the same time. Results: While the mean of anthropometric measures and dietary intake values remained unchanged during the study, MDA level decreased in ginger group (P=0.04) compared with placebo group. Additionally, ginger supplementation successfully lowered serum levels of TNF-α and disease activity index after 6 weeks of intervention compared with baseline in ginger consumer group, however the increase of quality of life score was not statistically significant in mentioned group versus baseline values. No significant change in other study outcomes was observed at the end of 6 weeks within and between groups. Conclusion: Our data indicates that two grams per day supplementation with dried ginger powder can reduce oxidative stress level of patients with active mild to moderate UC.
21. Study of regulatory T cells in patients with Crohn disease
- Author
-
Khalili, A., Mohammadnia-Afrouzi, M., Maleki, I., Hosseini, V., Taghvaei, T., Hossein-Nattaj, H., and saeid abediankenari
22. Polytelluride square planar chain-induced anharmonicity results in ultralow thermal conductivity and high thermoelectric efficiency in Al 2 Te 5 monolayers.
- Author
-
Maleki I, Allaei SMV, and Naghavi SS
- Abstract
Two-dimensional (2D) metal chalcogenides provide rich ground for the development of nanoscale thermoelectrics, although achieving optimal thermoelectric efficiency is still a challenge. Here, we leverage the unique chemistry of tellurium (Te), renowned for its hypervalent bonding and catenation abilities, to tackle this challenge as manifested in Al
2 Te3 and Al2 Te5 monolayers. While the former forms a straightforward covalent Al-Te network, the latter adopts a more intricate bonding mechanism, enabled by eccentric features of Te chemistry, to maintain charge balance. In Al2 Te5 , a square planar chain (SPC) known as polytelluride [Te3 ]2- is neutralized by the covalently bonded [Al2 Te2 ]2+ framework. The hypervalent nature of Te results in bizarre Born effective charges of 7 and -4 for adjacent Te atoms within the square planar chain, a feature that induces significant anharmonicity in Al2 Te5 monolayers. Enhanced anharmonic lattice vibrations and the accordion pattern bestow glass-like, strongly anisotropic thermal conductivity to the Al2 Te5 monolayer. The calculated κL values of 1.8 and 0.5 W m-1 K-1 along the a - and b -axes at 600 K are one order of magnitude lower than those of Al2 Te3 , and even lower than monolayers that contain heavy cations like Bi2 Te3 . Moreover, the tellurium chain dominates the valence band maximum and conduction band minimum of Al2 Te5 , leading to a high valley degeneracy of 10, and thus a high power factor and figure of merit ( zT ). Using rigorous first-principles calculations of electron relaxation time, the estimated hole-doped and electron-doped zT of, respectively, 1.5 and 0.5 at 600 K is achieved for Al2 Te5 . The pioneering zT of Al2 Te5 compared to that of Al2 Te3 is rooted merely in its amorphous-like lattice thermal transport and its polytelluride chain. These findings underscore the importance of aluminum telluride and polymeric-based inorganic compounds as practical and cost-effective thermoelectric materials, pending further experimental validation.- Published
- 2024
- Full Text
- View/download PDF
23. Sex and age differences in inflammatory bowel disease patients; a nationwide study based on Iranian Registry of Crohn's and Colitis (IRCC).
- Author
-
Khanmohammadi S, Sheidaei A, Alatab S, Tabatabaei-Malazy O, Vahedi H, Mansour-Ghanaei F, Fakheri H, Sheikhesmaeili F, Sadeghi A, Sima AR, Anushiravan A, Yazdanbod A, Moosavy SH, Maleki I, Vosooghinia H, Malekzadeh M, and Malekzadeh R
- Subjects
- Humans, Male, Female, Iran epidemiology, Adult, Middle Aged, Sex Factors, Young Adult, Age Factors, Adolescent, Aged, Inflammatory Bowel Diseases epidemiology, Registries, Crohn Disease epidemiology, Colitis, Ulcerative epidemiology
- Abstract
Background: Despite the rising prevalence of Inflammatory Bowel Disease (IBD), age and sex differences in its outcomes remain understudied. We investigated age and sex differences in IBD patients using a nationwide study in Iran, the Iranian Registry of Crohn's and Colitis (IRCC)., Methods: The IRCC is a national registry that gathered information on adult IBD patients since 2017. The collected data included demographic information, medication history, disease activity, comorbidities, diagnosis age, prognosis, the extent of ulcerative colitis (UC), Crohn's disease (CD) location, and extraintestinal manifestations. The statistical methods included the independent Student's t-test, Chi-square test, and binary logistic regression, using R version 4.2.2., Results: Among the 9,392 IBD patients, 7,496 (3,600 females) and 1,896 (808 females) had UC and CD, respectively. Sex difference showed higher odds of active disease in the past six months in male CD patients (OR 1.24 [95%CI 1.03, 1.49]) vs. females, but in male UC patients, the OR was 0.85 [0.78, 0.93]. Severe disease was less likely in CD patients aged 19-59 and >60 vs. <18. Similarly, UC patients <18 had lower odds of severe disease vs. those aged 19-59 and >60., Conclusions: This study emphasizes the importance of understanding age and sex differences in IBD outcomes. These findings contribute to the ongoing global discussion on IBD management and facilitate the development of targeted interventions and personalized care., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Khanmohammadi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
24. Beyond metals: theoretical discovery of semiconducting MAX phases and their potential application in thermoelectrics.
- Author
-
Khazaei M, Maleki I, Koshi NA, Ranjbar A, Miao N, Wang J, Khaledialidusti R, Kühne TD, Lee SC, Bhattacharjee S, Hosano H, Mehdi Vaez Allaei S, Esfarjani K, and Ohno K
- Abstract
MAX phase is a family of ceramic compounds, typically known for their metallic properties. However, we show here that some of them may be narrow bandgap semiconductors. Using a series of first-principles calculations, we have investigated the electronic structures of 861 dynamically stable MAX phases. Notably, Sc
2 SC, Y2 SC, Y2 SeC, Sc3 AuC2 , and Y3 AuC2 have been identified as semiconductors with band gaps ranging from 0.2 to 0.5 eV. Furthermore, we have assessed the thermodynamic stability of these systems by generating ternary phase diagrams utilizing evolutionary algorithm techniques. Their dynamic stabilities are confirmed by phonon calculations. Additionally, we have explored the potential thermoelectric efficiencies of these materials by combining Boltzmann transport theory with first-principles calculations. The relaxation times are estimated using scattering theory. The zT coefficients for the aforementioned systems fall within the range of 0.5 to 2.5 at temperatures spanning from 300 to 700 K, indicating their suitability for high-temperature thermoelectric applications.- Published
- 2024
- Full Text
- View/download PDF
25. Causes of Colectomy in Patients with Ulcerative Colitis: Findings from an Iranian National Registry.
- Author
-
Momayez Sanat Z, Vahedi H, Malekzadeh R, Kasaeian A, Mohammadi Ganjaroudi N, Sima A, Mansour Ghanaei F, Ghadir M, Tirgar Fakheri H, Nasseri Moghaddam S, Alatab S, Sadeghi A, Anushiravani A, Maleki I, Yazdanbod A, Vossoughinia H, Seyyedmajidi M, Naghshbandi SJ, Baniasadi N, Parhizkar B, Matinkhah S, Gheibi S, Hosseini Hemmat Abadi RS, and Valizadeh Toosi S
- Subjects
- Humans, Male, Iran epidemiology, Female, Adult, Middle Aged, Risk Factors, Young Adult, Age Factors, Aged, Adolescent, Colorectal Neoplasms surgery, Colorectal Neoplasms epidemiology, Colitis, Ulcerative surgery, Colectomy statistics & numerical data, Registries
- Abstract
Background: Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) marked by rectal and colon inflammation, leading to relapsing symptoms. Its prevalence is increasing, particularly in developed nations, impacting patients' health. While its exact cause remains unclear, genetic and environmental factors are implicated, elevating the risk of colorectal cancer (CRC). Colectomy, though declining, is still performed in select UC cases, necessitating further study., Methods: We analyzed data from the Iranian Registry of Crohn's and Colitis (IRCC) to examine UC patients undergoing colectomy. We collected demographic and clinical data from 91 patients, focusing on dysplasia. Statistical analyses assessed dysplasia risk factors., Results: Patients with dysplasia were older at diagnosis and surgery compared to those without dysplasia. Age emerged as a significant risk factor for dysplasia in UC patients undergoing colectomy. No significant associations were found between dysplasia and other factors., Conclusion: Age plays a crucial role in dysplasia risk among UC patients undergoing colectomy. Older age at diagnosis and surgery may indicate a higher risk of dysplasia and CRC. Clinicians should consider age when managing UC patients and implementing screening protocols. Further research with larger samples is needed to confirm these findings., (© 2024 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.)
- Published
- 2024
- Full Text
- View/download PDF
26. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
- Author
-
Saberzadeh-Ardestani B, Khosravi AA, Mansour-Ghanaei F, Vahedi H, Baniasadi N, Seyyedmajidi M, Parhizkar B, Hormati A, Naghshbandi SJ, Matin S, Hassan Zadeh AA, Taghvaei T, Bahrami M, Rafeey M, Ahadi M, Vossoughinia H, Muosavi H, Gheibi S, Hosseini-Hemmatabadi RS, Yazdanbod A, Matinkhah S, Sheikh Esmaeili F, Fakheri H, Moosavy SH, Maleki I, Nasseri-Moghaddam S, Khosravi B, Farahmand F, Najafi M, Alimadadi H, Malekzadeh M, Anushiravani A, Kasaeian A, Alatab S, Sadeghi A, Radmard AR, Kolahdoozan S, Rajabi Z, and Sima AR
- Subjects
- Humans, Iran epidemiology, Male, Female, Cross-Sectional Studies, Adult, Young Adult, Middle Aged, Adolescent, Crohn Disease epidemiology, Registries, Colitis, Ulcerative epidemiology, Phenotype
- Abstract
Background: Data on the epidemiology of inflammatory bowel disease (IBD) in the Middle East are scarce. We aimed to describe the clinical phenotype, disease course, and medication usage of IBD cases from Iran in the Middle East., Methods: We conducted a cross-sectional study of registered IBD patients in the Iranian Registry of Crohn's and Colitis (IRCC) from 2017 until 2022. We collected information on demographic characteristics, past medical history, family history, disease extent and location, extra-intestinal manifestations, IBD medications, and activity using the IBD-control-8 questionnaire and the Manitoba IBD index, admissions history, history of colon cancer, and IBD-related surgeries., Results: In total, 9746 patients with ulcerative colitis (UC) (n=7793), and Crohn's disease (CD) (n=1953) were reported. The UC to CD ratio was 3.99. The median age at diagnosis was 29.2 (IQR: 22.6,37.6) and 27.6 (IQR: 20.6,37.6) for patients with UC and CD, respectively. The male-to-female ratio was 1.28 in CD patients. A positive family history was observed in 17.9% of UC patients. The majority of UC patients had pancolitis (47%). Ileocolonic involvement was the most common type of involvement in CD patients (43.7%), and the prevalence of stricturing behavior was 4.6%. A prevalence of 0.3% was observed for colorectal cancer among patients with UC. Moreover,15.2% of UC patients and 38.4% of CD patients had been treated with anti-tumor necrosis factor (anti-TNF)., Conclusion: In this national registry-based study, there are significant differences in some clinical phenotypes such as the prevalence of extra-intestinal manifestations and treatment strategies such as biological use in different geographical locations., (© 2024 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.)
- Published
- 2024
- Full Text
- View/download PDF
27. Prevalence and risk factors of gastroesophageal reflux disease symptoms in Mazandaran, North of Iran: A Tabari cohort study.
- Author
-
Maleki I, Borhani S, Moosazadeh M, and Alizadeh-Navaei R
- Abstract
Background: Gastro-esophageal reflux disease (GERD) is a very common complaint. It is a major health concern and there is paucity of information about the epidemiology of the disease and its risk factors in Iran, especially Mazandaran province (North of Iran). This study aimed at investigating the prevalence of regurgitation and the factors associated with this condition in Tabari cohort study., Methods: This was a cross-sectional study that analyzed data from Tabari cohort study. Information including the presence and frequency of heartburn and regurgitation, demographic characteristics, socioeconomic status, occupational history, history of chronic illnesses, history of alcohol and cigarette consumption were recorded., Results: The prevalence of GERD symptoms were 27.6% (20.4% in men, and 32.4% in women, p=0.0001). The frequency of typical symptoms was significantly higher in women than that in men. The risk of developing GERD symptoms were 1.7 times higher in women (p=0.0001). The highest prevalence of GERD symptoms was found in urban areas (41.8%, p=0.0001), in people with low educational levels (48%, p=0.0001), and in participants with history of depression symptoms (36.2%, p=0.0001). The prevalence of GERD symptoms was significantly high in individuals with higher BMI (29.5%, p=0.006), greater waist to hip ratio (29.1%, p=0.0001, p=0.0001), and high waist circumference (31.7%, p=0.0001)., Conclusion: This study showed gender, region of residence, educational level, and depression symptoms as the main risk factors for developing GERD symptoms., Competing Interests: None to declare., (© The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
28. Epidemiological, Endoscopic, Clinical, and Pathological Features of Patients with Celiac Diseases in Southern Littoral of Caspian Sea.
- Author
-
Bari Z, Hadipour M, Fakheri H, Kazemi A, Maleki I, Taghvaei T, Hosseini V, Valizadeh SM, Masoumi D, Shahbazkhani B, Shokri Shirvani J, Tirgar Fakheri S, and Ebrahimi R
- Abstract
Background: Celiac disease is an autoimmune disorder resulting from gluten consumption in genetically predisposed individuals. The present study investigated the epidemiological, endoscopic, and clinicopathological features of patients with celiac disease in the southern littoral of the Caspian Sea. Methods: 140 patients with celiac disease were interviewed and examined regarding demographic characteristics, clinical symptoms, and serologic, endoscopic, and pathological findings. Results: 44 (31.4%) of the patients were male and 68.6% were female. The mean age of the patients at diagnosis was 27.13±13.4 years (ranging from 2 to 60 years). The most common gastrointestinal (GI) symptoms were bloating (47.8%), abdominal pain (47.1%) and diarrhea (30.7%), respectively. Also, 17 (12.1%) patients did not complain of any GI symptoms.18 (12.8%) patients had aphthous stomatitis, 10.7% had dermatitis herpetiformis, 3.6% suffered from itching without a rash, two (1.4%) mentioned psoriasis and one (0.7%) had lichen planus. 19 (19.7%) of the female patients complained of menstrual bleeding disorders, 4% mentioned infertility, and 2% experienced primary amenorrhea. The most common comorbid condition was hypothyroidism in 16 (11.4%) patients. The most common endoscopic finding was duodenal scalloping (37.25%). In addition, 7.8% of the patients had a normal endoscopic appearance. 43 (30.7%) patients were classified as Marsh IIIC, 25.7% Marsh IIIB, 17.8% Marsh IIIA, 12.8% Marsh II and 12.8% were classified as Marsh I. Conclusion: Since celiac disease can present with non-GI manifestations and the majority of our patients had Marsh III classification, it seems that celiac disease must be considered as a routine screening test in GI clinics, and also, it should be kept in mind as a differential diagnosis in other specialty fields., Competing Interests: Competing Interests The authors declare no conflict of interest related to this work., (© 2023 Middle East Journal of Digestive Diseases.)
- Published
- 2023
- Full Text
- View/download PDF
29. Comparison of Disease Phenotype and Course among Elderly- and Early-Onset Inflammatory Bowel Diseases in the Middle East.
- Author
-
Vosoghinia H, Saberzadeh-Ardestani B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, Vahedi H, Sheikhesmaeili F, Yazdanbod A, Moosavy SH, Maleki I, Nasseri-Moghaddam S, Khosravi B, Malekzadeh M, Kasaeian A, Alatab S, Sadeghi A, Kolahdoozan S, Amani M, Saberhosseini SN, Rayatpisheh M, Ahadi M, Colombel JF, Ungaro RC, Sima AR, and Malekzadeh R
- Subjects
- Humans, Aged, Retrospective Studies, Iran, Tumor Necrosis Factor Inhibitors, Immunologic Factors, Prednisolone therapeutic use, Phenotype, Inflammatory Bowel Diseases epidemiology, Inflammatory Bowel Diseases complications, Inflammatory Bowel Diseases diagnosis, Colitis, Ulcerative drug therapy, Colitis, Ulcerative epidemiology, Colitis, Ulcerative complications, Crohn Disease drug therapy, Crohn Disease epidemiology, Crohn Disease complications
- Abstract
Background: It is unknown if the clinical manifestations and phenotype of disease are comparable between early- and elderly-onset inflammatory bowel disease (IBD). We aimed to seek differences in disease phenotype, course, complications, and treatment between early- and elderly-onset IBD patients., Methods: This retrospective cohort study on registered IBD patients in the Iranian Registry of Crohn's and Colitis (IRCC) compared demographics, disease phenotype, disease activity, IBD-related surgery and medications between early- and elderly-onset IBD. A generalized linear regression model was used to investigate the relative risk of age at diagnosis adjusted for gender and disease duration for the outcomes., Results: From 10048 IBD patients, 749 with early-onset (7.5%), and 472 (4.7%) elderly-onset IBD were enrolled: 855 (63.1%) ulcerative colitis (UC) and 366 (26.9%) Crohn's disease (CD). Left-sided colitis was more frequent among elderly-onset UC patients ( P <0.001). Ileum and ileocolonic locations were the most common types in elderly-onset and early-onset CD patients, respectively. In comparison with elderly-onset UC, early-onset cases more often used prednisolone (22.1% vs. 11.4%, P =0.001), immunomodulators (44.9% vs 25.2%, P <0.001) and anti-tumor necrosis factors (TNF) (20.1% vs 11.9%, P =0.002). Elderly-onset UC patients had 0.7 times lower risk of aggressive phenotype (95%CI:0.6‒0.9, P =0.005). Early-onset CD was associated with higher use of prednisolone (27.7% vs 8.1%, P <0.001), immunomodulators (58.7% vs 41.8%, P =0.005) and anti-TNF (49.6% vs 35.4%, P =0.006)., Conclusion: Early-onset IBD was associated with a more aggressive phenotype and higher prednisolone, immunomodulators, and anti-TNF use., (© 2023 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.)
- Published
- 2023
- Full Text
- View/download PDF
30. Non-inferiority of reverse hybrid regimen versus standard concomitant regimen for H. pylori eradication in a randomized-controlled trial.
- Author
-
Valizadeh Toosi SM, Maleki I, Hosseini V, and Shokri-Afra H
- Abstract
Background: Helicobacter pylori ( H. pylori ) infection is strongly related to peptic ulcer disease, chronic gastritis, and gastric malignancies. Therefore, H. pylori eradication is necessary in these cases. This study was aimed to compare the efficacy of 14-day reverse hybrid therapy with standard 14-day concomitant regimen for H. pylori eradication in Iran., Methods: Of the 317 patients with dyspepsia and H. pylori infection enrolled in the study, 153 and 164 patients were randomly assigned to reverse hybrid and concomitant groups, respectively. The reverse hybrid regimen containing pantoprazole, amoxicillin, clarithromycin, and metronidazole was taken every 12 hours in the first 7 days, however, Clarithromycin and Metronidazole were discontinued within the next 7 days. Patients in the concomitant group also received the same drugs for 14-day. Eradication confirmation tests were used 8 weeks after the end of treatments., Results: A crowd of 281 patients continued the trial until the end. H. pylori eradication rates based on intention to treat analysis were 71.2% (109/153) and 83.5% (137/164) in reverse hybrid and concomitant groups, respectively ( P = 0.007). By the per-protocol analysis, rates of eradication were 85.8% (109/127) and 89% (137/154), respectively ( P = 0.428). Severe side effects were few in both groups. More side effects were observed in concomitant group ( p < 0.001), however, the severity of side effects was not statistically different between the two regimens ( P = 0.314). Reverse hybrid regimen was better tolerated (98% vs. 91.5%, P = 0.009)., Conclusion: Both 14-day reverse hybrid and concomitant regimens have a fair response rate in Iran., Competing Interests: The authors declare that they have nothing to disclose.
- Published
- 2023
- Full Text
- View/download PDF
31. Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication.
- Author
-
Kazemi Veysari A, Rahimi A, Maleki I, Tirgar Fakheri H, Taghvaei T, Hosseini V, Valizadeh Toosi SM, Masoumi D, and Bari Z
- Abstract
Background: Helicobacter pylori ( H. pylori ) has infected about 50% of the world's population and it is the main cause for peptic ulcer, gastric adenocarcinoma and even a major cause for gastric MALT lymphoma., Methods: This study was performed in Mazandaran, Sari, situated in North of Iran. Three-hundred and twenty-eight adult patients with endoscopically approved gastric or duodenal ulcers or erosions and H. pylori infection were randomly divided into 2 groups to receive either 14 days PABT (Pantoprazole 40 mg, Amoxicillin 1 g, Bismuth 425 mg (all twice daily) and Tetracycline 500 mg four times a day) and PACM (Pantoprazole 40 mg, Amoxicillin 1g, Clarithromycin 500 mg, and Metronidazole 500 mg, all twice daily). To evaluate H. pylori eradication, fecal H. pylori antigen test was performed 8 weeks after treatment., Results: The eradication rates were 94.51% in the PABT and 91.46% in PACM group based on the intention to treat analysis. Moreover, the eradication rates were 95.58% and 92.72% according to per-protocol analysis, respectively. Also, both groups had very low rates of severe side effects., Conclusion: Regarding the ideal eradication rates achieved by both treatment groups and the low rates of severe side effects, both treatment protocols can be prescribed for H. pylori eradication in North of Iran., Competing Interests: Nothing to be declared.
- Published
- 2023
- Full Text
- View/download PDF
32. Face-to-face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population-based research.
- Author
-
Sperber AD, Bor S, Fang X, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fukudo S, Kellow J, Okeke E, Quigley EMM, Schmulson M, Whorwell P, Archampong T, Adibi P, Andresen V, Benninga MA, Bonaz B, Fernandez LB, Choi SC, Corazziari ES, Francisconi C, Hani A, Lazebnik L, Lee YY, Mulak A, Rahman MM, Santos J, Setshedi M, Syam AF, Vanner S, Wong RK, Lopez-Colombo A, Costa V, Dickman R, Kanazawa M, Keshteli AH, Khatun R, Maleki I, Poitras P, Pratap N, Stefanyuk O, Thomson S, Buyruk M, Unal N, Huang D, Song J, Hreinsson JP, and Palsson OS
- Subjects
- Humans, Rome, Surveys and Questionnaires, China epidemiology, Turkey, Gastrointestinal Diseases
- Abstract
Background and Aims: The Rome Foundation Global Epidemiology Study (RFGES) assessed the prevalence, burden, and associated factors of Disorders of Gut-Brain Interaction (DGBI) in 33 countries around the world. Achieving worldwide sampling necessitated use of two different surveying methods: In-person household interviews (9 countries) and Internet surveys (26 countries). Two countries, China and Turkey, were surveyed with both methods. This paper examines the differences in the survey results with the two methods, as well as likely reasons for those differences., Methods: The two RFGES survey methods are described in detail, and differences in DGBI findings summarized for household versus Internet surveys globally, and in more detail for China and Turkey. Logistic regression analysis was used to elucidate factors contributing to these differences., Results: Overall, DGBI were only half as prevalent when assessed with household vs Internet surveys. Similar patterns of methodology-related DGBI differences were seen within both China and Turkey, but prevalence differences between the survey methods were dramatically larger in Turkey. No clear reasons for outcome differences by survey method were identified, although greater relative reduction in bowel and anorectal versus upper gastrointestinal disorders when household versus Internet surveying was used suggests an inhibiting influence of social sensitivity., Conclusions: The findings strongly indicate that besides affecting data quality, manpower needs and data collection time and costs, the choice of survey method is a substantial determinant of symptom reporting and DGBI prevalence outcomes. This has important implications for future DGBI research and epidemiological research more broadly., (© 2023 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
33. Evaluation of Circulating Leptin and Its Receptor (Ob-R) Tissue Expression in Colorectal Cancer, a Report From North of Iran.
- Author
-
Mahmoudi-Nesheli M, Alizadeh-Navaei R, Vahedi L, Amjadi O, Taghvaei T, Maleki I, Shekarriz R, Kazemi A, Omrani-Nava V, and Alizadeh-Foroutan M
- Abstract
Background & Objective: Leptin is an adipocyte-derived hormone with a critical role in energy balance. As demonstrated by previous investigations, leptin acts as a proliferative and angiogenic factor in cancer cells. However, results regarding its role in colorectal cancer are still inconclusive. We aimed to evaluate serum leptin and tissue expression of leptin receptor (Ob-R) in normal and malignant samples of colorectal., Methods: Serum and tissue samples from pathology-confirmed colorectal cancer patients and normal controls referring to a university hospital of Mazandaran were obtained during 2019-21. ELISA and immunohistochemistry were applied to determine leptin and Ob-R expression respectively., Results: A total of 90 samples belonging to 46 normal and 44 CRC patients were enrolled. Normal and CRC groups included 32 (69.56%) and 21 (47.72%) female subjects respectively. The average leptin concentration in the normal group was 115.80 and, in the patient, group was 124.47 ng/mL ( P =0.897). CRC cases showed an insignificantly higher Ob-R detection rate ( P =0.086)., Conclusion: There was no significant difference in leptin and Ob-R expression between CRC patients and normal subjects. Thus, leptin and its receptor may not be useful as a biomarker of CRC., Competing Interests: None.
- Published
- 2023
- Full Text
- View/download PDF
34. Role of BTLA/HVEM network in development of gastric cancer.
- Author
-
Azarafza M, Tehrani M, Valadan R, Maleki I, Mohammad Mehdi Ghaffari-Hamedani S, Ghanadan A, Alizadeh-Navaei R, and Ajami A
- Subjects
- Humans, Metaplasia metabolism, Receptors, Immunologic genetics, Receptors, Immunologic metabolism, T-Lymphocytes, Receptors, Tumor Necrosis Factor, Member 14 genetics, Receptors, Tumor Necrosis Factor, Member 14 metabolism, Stomach Neoplasms genetics
- Abstract
The immunopathological mechanism underlying intestinal metaplasia and gastric cancer remain incompletely understood. Regarding the role of B- and T-lymphocyte attenuator (BTLA) / herpesvirus entry mediator (HVEM) in tumorigenesis, this research was conducted to determine the BTLA/HVEM expression in development of gastric cancer. Gastric biopsy and peripheral blood was drawn from 32 non-ulcer dyspepsia (NUD) as control group, 19 intestinal metaplasia (IM), and 63 gastric cancer (GC). BTLA/HVEM expression were analyzed by immunohistochemistry and quantitative real-time polymerase chain reaction. Soluble HVEM (sHVEM) and anti-Helicobacter pylori IgG antibody were assessed by ELISA. Our result showed that BTLA mRNA and protein were significantly increased in advanced stages of gastric cancer. HVEM was higher only at the protein level in the GC group. The sHVEM concentration was also higher in the GC group than in the NUD groups. In addition, we observed H. pylori-positive samples had a lower H-score of HVEM than H. pylori-negative ones. These results suggest that BTLA/HVEM/sHVEM inhibitory pathway is involved in immune regulation and progression of gastric cancer. Therefore, this inhibitory pathway might be a therapeutic target to further immunotherapy of gastric cancer., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
35. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
- Author
-
Saberzadeh-Ardestani B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, Vahedi H, Sheikhesmaeili F, Yazdanbod A, Moosavy SH, Vosoghinia H, Maleki I, Nasseri-Moghaddam S, Khosravi B, Malekzadeh M, Kasaeian A, Alatab S, Sadeghi A, Kolahdoozan S, Rayatpisheh M, Sima AR, and Malekzadeh R
- Subjects
- Case-Control Studies, Chronic Disease, Disease Progression, Humans, Iran, Phenotype, Prospective Studies, Tumor Necrosis Factor Inhibitors, Colitis, Ulcerative diagnosis, Colitis, Ulcerative epidemiology, Colitis, Ulcerative genetics, Colonic Neoplasms, Crohn Disease diagnosis, Crohn Disease epidemiology, Crohn Disease genetics, Inflammatory Bowel Diseases diagnosis, Inflammatory Bowel Diseases epidemiology, Inflammatory Bowel Diseases genetics
- Abstract
Background: The role of genetic and environmental factors in inflammatory bowel disease's (IBD) clinical course is not fully clear. We aimed to assess the clinical phenotype, disease course, and prognosis of familial IBD in comparison with sporadic cases., Methods: We conducted a prospective national matched case-control study of registered IBD patients in the Iranian Registry of Crohn's and Colitis (IRCC) recruited from 2017 until 2020. Sporadic and familial IBD patients were matched based on age, sex, and disease duration. Data on demographics, past medical disease, family history of IBD, disease type, clinical phenotype, extraintestinal manifestations, IBD medications, IBD activity using the IBD-control-8 questionnaire and the Manitoba IBD index, emergency visits in the past 12 months, admissions in the past 3 months, history of colon cancer, IBD-related surgeries, and aggressive phenotype were gathered. Variable distributions were compared between sporadic and familial cases., Results: Overall, 5231 patients with ulcerative colitis (UC, 18.3% familial) and 1438 patients with Crohn's disease (CD, 16.7% familial) were registered in the IRCC. Age at diagnosis was similar between familial and sporadic cases. After matching, 3523 UC patients and 908 CD patients were enrolled in the study. Extraintestinal manifestations, UC extent, CD location and behavior, anti-TNF use, disease activity, colon cancer, IBD-related surgeries and the aggressive phenotype were similar between these sporadic and familial cases., Conclusions: The prevalence of familial UC and CD cases in Iran was more similar to western countries, and family history did not show a predictive value for disease phenotype, course, and outcomes in our study., (© 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
36. Susceptibility of Patients with Inflammatory Bowel Disease to COVID-19 Compared with Their Households.
- Author
-
Anushiravani A, Saberzadeh-Ardestani B, Vahedi H, Fakheri H, Mansour-Ghanaei F, Maleki I, Nasseri-Moghaddam S, Vosoghinia H, Ghadir MR, Hormati A, Kasaeian A, Radmard AR, Khosravi B, Malekzadeh M, Alatab S, Sadeghi A, Aminisani N, Poustchi H, Sima AR, and Malekzadeh R
- Abstract
BACKGROUND : Immunosuppressive agents used in the treatment of inflammatory bowel diseases (IBDs) could potentially increase the risk of coronavirus disease 2019 (COVID-19). We aimed to compare COVID-19 frequency in patients with IBD with their households and identify the related risk factors. METHODS : Firstly, a multi-centered, observational study on 2110 patients with IBD and 2110 age-matched household members was conducted to compare COVID-19 frequency. Secondly, the data of patients with IBD and COVID-19 who had called the COVID-19 hotline were added. Multivariable logistic regression was used to evaluate the effect of age, type and severity of IBD, the number of comorbidities, and medications on the frequency of COVID-19 among the patients with IBD. RESULTS : The prevalence of COVID-19 in patients with IBD and household groups was similar (34 [1.61%] versus 35 [1.65%]; P = 0.995). The prevalence of COVID-19 increased from 2.1% to 7.1% in those with three or more comorbidities ( P = 0.015) and it was significantly higher in those with severe IBD ( P = 0.026). The multivariable analysis only showed a significant association with anti-TNF monotherapy (OR: 2.5, CI: 0.97-6.71, P = 0.05), and other medications were not associated with COVID-19. CONCLUSION : The prevalence of COVID-19 in patients with IBD was similar to the household members. Only patients with IBD receiving anti-TNF monotherapy had a higher risk of COVID-19 susceptibility. This finding could be attributed to the higher exposure to the virus during administration in health care facilities., Competing Interests: CONFLICT OF INTEREST The authors declare no conflict of interest related to this work., (© 2022 Middle East Journal of Digestive Diseases.)
- Published
- 2022
- Full Text
- View/download PDF
37. Efficacy of 14-day concomitant quadruple therapy and 14-day high-dose dual therapy on H. pylori eradication.
- Author
-
Yadollahi B, Valizadeh Toosi SM, Bari Z, Fakheri H, Maleki I, Taghvaei T, Hosseini V, Kazemi A, and Shokri-Afra H
- Abstract
Aim: We compared the efficacy of two different regimens for H . pylori eradication in areas with high antibiotic resistance., Background: Helicobacter pylori ( H. pylori ) is a gram-negative bacillus that has a strong association with chronic gastritis and peptic ulcer disease. Different regimens with varying degrees of effectiveness have been used for H. pylori eradication., Methods: The current randomized controlled trial (RCT) randomly assigned 217 patients who had indications for H . pylori eradication therapy to two groups. One group were administered concomitant quadruple therapy (pantoprazole 40 mg, amoxicillin 1 gr, clarithromycin 500 mg, and metronidazole 500 mg every 12 hours) for 14 days, and the second group received 14 days of high-dose dual therapy, consisting of esomeprazole 40 mg BID and amoxicillin 1g TDS. H. pylori eradication was assessed eight weeks after the end of treatment., Results: H. pylori eradication rates by PP analysis for 14 days concomitant quadruple therapy and high-dose dual therapy were 88.6% (95% CI, 80.3-92.8) and 82.2% (95% CI, 74.8-89.5), respectively ( p = 0.19). According to intention-to-treat (ITT) analysis, the eradication rates were 81.6% (95% CI, 74.5-88.6) and 80.6% (95% CI, 73-88.1), respectively ( p = 0.58). Overall drug side effects were 20.8% in high-dose dual therapy and 49.6% in concomitant quadruple therapy ( p < 0.001)., Conclusion: Fourteen days concomitant quadruple therapy can be considered as a relatively acceptable regimen for H. pylori eradication in areas with high clarithromycin and metronidazole resistance. It seems that high-dose dual therapy could be a promising alternative regimen in these areas., Competing Interests: The authors declare that they have no conflict of interest., (©2022 RIGLD, Research Institute for Gastroenterology and Liver Diseases.)
- Published
- 2022
38. Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD Medications.
- Author
-
Sima AR, Saberzadeh-Ardestani B, Vahedi H, Fakheri H, Mansour-Ghanaei F, Maleki I, Nasseri-Moghaddam S, Vosoghinia H, Ghadir MR, Hormati A, Kasaeian A, Radmard AR, Khosravi B, Malekzadeh M, Alatab S, Sadeghi A, Aminisani N, Poustchi H, Gonoudi E, Anushiravani A, Rayatpisheh M, Colombel JF, Ungaro RC, and Malekzadeh R
- Subjects
- Humans, Prospective Studies, SARS-CoV-2, Tumor Necrosis Factor Inhibitors, COVID-19, Inflammatory Bowel Diseases drug therapy, Inflammatory Bowel Diseases epidemiology
- Abstract
Background: Most data on the effect of inflammatory bowel disease (IBD) and its treatments on coronavirus disease 2019 (COVID-19) outcomes have not had non-IBD comparators. Hence, we aimed to describe COVID-19 outcomes in IBD compared to non-IBD patients., Methods: We conducted a prospective cohort study of registered IBD patients with confirmed COVID-19 from six provinces in Iran from February to April 2020. Proven COVID-19 patients were followed up at four weeks and the frequency of outcomes was assessed. Multivariable logistic regression was used to assess associations between demographics, clinical characteristics and COVID-19 outcomes., Results: Overall, 2159 IBD patients and 4721 household members were enrolled, with 84 (3.9%) and 49 (1.1%) participants having confirmed COVID-19, respectively. Household spread of COVID-19 was not common in this cohort (1.2%). While hospitalization was significantly more frequent in IBD patients compared with non-IBD household members (27.1% vs. 6.0%, P =0.002), there was no significant difference in the frequency of severe cases. Age and presence of IBD were positively associated with hospitalization in IBD compared with non-IBD household members (OR: 1.06, 95% CI: 1.03-1.10; OR: 5.7, 95% CI: 2.02- 16.07, respectively). Age, presence of new gastrointestinal symptoms, and 5-aminosalicylic acid (5-ASA) use were associated with higher hospitalization rate in IBD patients (OR: 1.13, 95% CI: 1.05-1.23; OR: 6.49, 95% CI: 1.87-22.54; OR: 6.22, 95% CI: 1.90-20.36, respectively). Anti-tumor necrosis factor (TNF) was not associated with more severe outcomes., Conclusion: Age, presence of new gastrointestinal symptoms and use of 5-ASA were associated with increased hospitalization rate among IBD patients, while anti-TNF therapy had no statistical association., (2022 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons. org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.)
- Published
- 2022
- Full Text
- View/download PDF
39. Immunologic markers, vasculitis-associated autoantibodies, and complement levels in patients with COVID-19.
- Author
-
Mobini M, Ghasemian R, Vahedi Larijani L, Mataji M, and Maleki I
- Abstract
Background: The cause of coronavirus disease 2019 (COVID-19) is a virus which can lead to severe acute respiratory syndrome-CoV-2 (SARS-COV-2). There are evidences of involvement of immune system in pathogenesis of this disease. We investigated the presence of various vasculitis-associated autoantibodies and complement levels in patients with COVID-19., Materials and Methods: Patients with severe or critical type of COVID-19 were evaluated for symptoms, signs, and laboratory tests of vasculitis syndromes including rheumatoid factor (RF), antinuclear antibody (ANA), anti-double-stranded DNA, c and p anti-neutrophilic cytoplasmic antibody (c ANCA and P ANCA), and complement levels., Results: The study was performed in forty patients with severe or critical illness. The mean age of the participants was 48.5 ± 9.8 years. All patients had pulmonary involvement in lung computed tomography scans. Vasculitis laboratory test results included RF in two patients, ANA in three patients, and ANCA in one patient. Seventeen (42.5%) patients had hypocomplementemia in one or more complement tests. Four patients expired, of whom three had a decrease in complement level., Conclusion: Decrease in complement levels may predict a critical state of COVID-19 disease. Therefore, measuring its levels may be of great benefit in making earlier decisions to initiate disease-suppressing treatments including corticosteroids., Competing Interests: There are no conflicts of interest., (Copyright: © 2021 Journal of Research in Medical Sciences.)
- Published
- 2021
- Full Text
- View/download PDF
40. Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial.
- Author
-
Merat S, Sharifi AH, Poustchi H, Hajiani E, Gharavi A, Karimi J, Mansour-Ghanaei F, Fattahi MR, Ahmadi L, Somi MH, Kalantari H, Ghadir MR, Sheikhesmaeili F, Baniasadi N, Sohrabi M, Moosavy S, Ziaee M, Zahedi MJ, Mokhtare M, Sali S, Sayad B, Afshar B, Bakhshipour A, Parsi A, Sharifian A, Amiriani T, Malekzadeh Z, Merat D, Ganji A, Rahmani-Samani F, Jamali R, Sofian M, Ghezlou M, Sohrabpour AA, Goshayeshi L, Valizadeh-Toosi SM, Eslami L, Maleki I, Hormati A, Shayesteh AA, Shayesteh E, Norouzi A, Abna Z, Janbakhsh A, Fakheri H, Minakari M, Sardarian H, Ghajary AFA, Fattahi-Abdizadeh M, Latifnia M, Roozbeh F, Agah S, Fakhrieh-Asl S, Nateghi-Baygi A, Fattahi B, Nateghi-Baygi H, Hill A, and Malekzadeh R
- Published
- 2021
- Full Text
- View/download PDF
41. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.
- Author
-
Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, Kellow J, Okeke E, Quigley EMM, Schmulson M, Whorwell P, Archampong T, Adibi P, Andresen V, Benninga MA, Bonaz B, Bor S, Fernandez LB, Choi SC, Corazziari ES, Francisconi C, Hani A, Lazebnik L, Lee YY, Mulak A, Rahman MM, Santos J, Setshedi M, Syam AF, Vanner S, Wong RK, Lopez-Colombo A, Costa V, Dickman R, Kanazawa M, Keshteli AH, Khatun R, Maleki I, Poitras P, Pratap N, Stefanyuk O, Thomson S, Zeevenhooven J, and Palsson OS
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Female, Gastrointestinal Diseases diagnosis, Humans, Male, Middle Aged, Prevalence, Sex Distribution, Surveys and Questionnaires, Young Adult, Gastrointestinal Diseases epidemiology, Global Health
- Abstract
Background & Aims: Although functional gastrointestinal disorders (FGIDs), now called disorders of gut-brain interaction, have major economic effects on health care systems and adversely affect quality of life, little is known about their global prevalence and distribution. We investigated the prevalence of and factors associated with 22 FGIDs, in 33 countries on 6 continents., Methods: Data were collected via the Internet in 24 countries, personal interviews in 7 countries, and both in 2 countries, using the Rome IV diagnostic questionnaire, Rome III irritable bowel syndrome questions, and 80 items to identify variables associated with FGIDs. Data collection methods differed for Internet and household groups, so data analyses were conducted and reported separately., Results: Among the 73,076 adult respondents (49.5% women), diagnostic criteria were met for at least 1 FGID by 40.3% persons who completed the Internet surveys (95% confidence interval [CI], 39.9-40.7) and 20.7% of persons who completed the household surveys (95% CI, 20.2-21.3). FGIDs were more prevalent among women than men, based on responses to the Internet survey (odds ratio, 1.7; 95% CI, 1.6-1.7) and household survey (odds ratio, 1.3; 95% CI, 1.3-1.4). FGIDs were associated with lower quality of life and more frequent doctor visits. Proportions of subjects with irritable bowel syndrome were lower when the Rome IV criteria were used, compared with the Rome III criteria, in the Internet survey (4.1% vs 10.1%) and household survey (1.5% vs 3.5%)., Conclusions: In a large-scale multinational study, we found that more than 40% of persons worldwide have FGIDs, which affect quality of life and health care use. Although the absolute prevalence was higher among Internet respondents, similar trends and relative distributions were found in people who completed Internet vs personal interviews., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
42. Invasion front dynamics in disordered environments.
- Author
-
Azimzade Y, Sasar M, and Maleki I
- Abstract
Invasion occurs in environments that are normally spatially disordered, however, the effect of such a randomness on the dynamics of the invasion front has remained less understood. Here, we study Fisher's equation in disordered environments both analytically and numerically. Using the Effective Medium Approximation, we show that disorder slows down invasion velocity and for ensemble average of invasion velocity in disordered environment we have [Formula: see text] where [Formula: see text] is the amplitude of disorder and [Formula: see text] is the invasion velocity in the corresponding homogeneous environment given by [Formula: see text]. Additionally, disorder imposes fluctuations on the invasion front. Using a perturbative approach, we show that these fluctuations are Brownian with a diffusion constant of: [Formula: see text]. These findings were approved by numerical analysis. Alongside this continuum model, we use the Stepping Stone Model to check how our findings change when we move from the continuum approach to a discrete approach. Our analysis suggests that individual-based models exhibit inherent fluctuations and the effect of environmental disorder becomes apparent for large disorder intensity and/or high carrying capacities.
- Published
- 2020
- Full Text
- View/download PDF
43. A Supporting System for Management of Patients with Inflammatory Bowel Disease during COVID-19 Outbreak: Iranian Experience-Study Protocol.
- Author
-
Anushiravani A, Vahedi H, Fakheri H, Mansour-Ghanaei F, Maleki I, Nasseri-Moghaddam S, Vosoghinia H, Ghadir MR, Hormati A, Aminisani N, Radmard AR, Khosravi B, Saberzadeh-Ardestani B, Malekzadeh M, Alatab S, Sadeghi A, Salahi S, Malekzadeh R, and Sima AR
- Abstract
BACKGROUND The COVID-19 pandemic has affected the health care infrastructure dramatically, with abundant resources necessarily being redirected to COVID-19 patients and their care. Also, patients with chronic diseases like inflammatory bowel disease (IBD) may be affected in several ways during this pandemic. METHODS We used the Iranian registry of Crohn's and colitis (IRCC) infrastructure. We called and sent messages to follow-up and support the care of all registered patients. Besides, we prepared and distributed educational materials for these patients and physicians to reduce the risk of COVID-19 infection. We risk-stratified them and prepared outpatient clinics and hospitalization guidance for IBD patients. RESULTS Of 13165 Iranian patients with IBD, 51 have been diagnosed as having COVID-19. IBD patients made 1920 hotline calls. Among the patients with suspicious presentations, 14 COVID-19 infections were diagnosed. Additionally, 1782 patients with IBD from five provinces actively phone-called among whom 28 definite cases were diagnosed. CONCLUSION IBD patients' follow-up could help in diagnosing the affected IBD patients with COVID-19. Additionally, the performance of protective actions and preparing the patients and physicians for decisive proceedings are the principles of protection of IBD patients., Competing Interests: CONFLICT OF INTEREST The authors declare no conflict of interest related to this work., (© 2020 Middle East Journal of Digestive Diseases.)
- Published
- 2020
- Full Text
- View/download PDF
44. The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment.
- Author
-
Poustchi H, Majd Jabbari S, Merat S, Sharifi AH, Shayesteh AA, Shayesteh E, Minakari M, Fattahi MR, Moini M, Roozbeh F, Mansour-Ghanaei F, Afshar B, Mokhtare M, Amiriani T, Sofian M, Somi MH, Agah S, Maleki I, Latifnia M, Fattahi Abdizadeh M, Hormati A, Khoshnia M, Sohrabi M, Malekzadeh Z, Merat D, and Malekzadeh R
- Subjects
- Carbamates, Drug Therapy, Combination, Female, Hepatitis C complications, Hepatitis C virology, Humans, Liver Cirrhosis complications, Male, Pyrrolidines, Renal Dialysis, Safety, Severity of Illness Index, Sofosbuvir adverse effects, Sustained Virologic Response, Treatment Outcome, Valine analogs & derivatives, Antiviral Agents administration & dosage, Hepatitis C drug therapy, Imidazoles administration & dosage, Renal Insufficiency complications, Sofosbuvir administration & dosage
- Abstract
Background and Aim: Many of the treatment regimens available for hepatitis C include sofosbuvir. Unfortunately, sofosbuvir has not been recommended for use in patients with severe renal impairment leaving these group of patients with very few options. Nevertheless, there are many reports in which these patients have been treated with sofosbuvir-containing regiments without important adverse events. This study aims at determining the safety and effectiveness of a sofosbuvir-based treatment in patients with severe renal impairment, including those on hemodialysis., Method: We enrolled subjects with hepatitis C and estimated glomerular filtration rate under ml/min/1.73m
2 from 13 centers in Iran. Patients were treated for 12 weeks with a single daily pill containing 400-mg sofosbuvir and 60-mg daclatasvir. Patients with cirrhosis were treated for 24 weeks. Response to treatment was evaluated 12 weeks after end of treatment (sustained viral response [SVR]). ClinicalTrials.gov identifier: NCT03063879., Results: A total of 103 patients were enrolled from 13 centers. Seventy-five patients were on hemodialysis. Thirty-nine had cirrhosis and eight were decompensated. Fifty-three were Genotype 1, and 27 Genotype 3. Twenty-seven patients had history of previous failed interferon-based treatment. Three patients died in which cause of death was not related to treatment. Six patients were lost to follow-up. The remaining 94 patients all achieved SVR. No adverse events leading to discontinuation of medicine was observed., Conclusions: The combination of sofosbuvir and daclatasvir is an effective and safe treatment for patients infected with all genotypes of hepatitis C who have severe renal impairment, including patients on hemodialysis., (© 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.)- Published
- 2020
- Full Text
- View/download PDF
45. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis.
- Author
-
Eslamijouybari M, Heydari K, Maleki I, Moosazadeh M, Hedayatizadeh-Omran A, Vahedi L, Ghasemian R, Sharifpour A, and Alizadeh-Navaei R
- Abstract
Background: The present study aimed to compare the complete blood count (CBC) indices between COVID-19 patients and the control group, and assess the relationship of these indices with COVID-19 prognosis., Methods: COVID-19 patients (confirmed by PCR or CT-Scan) who visited Imam Hospital in Sari were selected in this case-control study. The control group was selected from Tabari cohort population matched with the case group in terms of gender and age. CBC, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcome of the disease (in the case group) were assessed in this study., Results: The number of participants were 527 in both case and control groups, of which, 232 (44%) were females in each arms. Platelet count, lymphocyte count, and hemoglobin concentration were also higher in the control group (P=0.000). NLR and PLR were significantly higher in COVID-19 patients compared to the control group (P=0.000). NLR had a significant relationship with the severity of the disease. NLR was two times higher in the patients who died of COVID-19 than those who recovered (P=0.000). ROC curve analysis for diagnostic values of NLR and PLR showed that the areas under the ROC curves for NLR and PLR were 0.703 (95% CI: 0.64-0.76) and 0.535 (95% CI: 0.46-06), respectively., Conclusion: NLR can be used as a prognostic marker for COVID-19 given the significant difference of NLR between those who died and recovered from COVID-19.
- Published
- 2020
- Full Text
- View/download PDF
46. Positive association between severity of COVID-19 infection and liver damage: a systematic review and meta-analysis.
- Author
-
Shokri Afra H, Amiri-Dashatan N, Ghorbani F, Maleki I, and Rezaei-Tavirani M
- Abstract
Aim: The current study aimed to report a pooled analysis of the association of the circulating levels of liver enzymes and total bilirubin with severe and non-severe COVID-19., Background: The ongoing coronavirus outbreak is an important threat to health worldwide. Epidemiological data representing greater risk of liver failure in patients infected with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)., Methods: Electronic databases were comprehensively searched using Medline, ISI Web of Science, EMBASE, and the Cochrane Library up to July 2020. Outcomes from each relevant study were pooled using a random-effects model. Heterogeneity was analyzed by Q test and I
2 statistics. Sensitivity analysis was also evaluated., Results: A total of 24 studies were included (4,246 patients) in this study. We found a significant association of COVID-19 severity with increased levels of ALT [SMD: 1.40 U/L; 95% CI (0.93, 1.88); P < 0.05, I2 = 96.5%, PHeterogenity = < 0.05, I P < 0.05, I2 = 97.9%, P < 0.05, IHeterogenity = 0.000], LDH [SMD: 3.88 U/L; 95% CI (2.70, 5); P < 0.05, I2 = 0.001, I PHeterogenity = 0.000] and TBil [SMD: 1.08 mol/L; 95% CI (0.44, 1.72); P = 0.001, I2 = 97.7, PHeterogenity = 0.000], whereas, ALP values [SMD: 0.31; 95% CI (-1.57, 2.20); P = 0.74] was not significant between severe and non-severe COVID-19 patients. Moreover, elevated liver enzymes were found more in males [OR: 1.52, (95% CI 1.26, 1.83), P < 0.05] with severe COVID-19 infection than in females., Conclusion: The alterations of liver function indexes caused by SARS-CoV-2 infection suggested a potential prognosis biomarker for screening of severe patients at early stages of the disease.- Published
- 2020
47. Evaluation of demographic, pathologic, and clinical characteristics and overall survival of patients with colon cancer in Northern Iran (Mazandaran Province) during 2012-2019.
- Author
-
Rahimi E, Yazdani Charati J, Mohammad Pour Tahamtan R, and Maleki I
- Abstract
Aim: The present study aimed at evaluating the demographic, pathological and clinical characteristics of patients with colon cancer and also the survival rate and its related factors., Background: Cancer is the most important barrier to increasing life expectancy in the world. Furthermore, colon cancer is the fourth leading cause of cancer in Iran., Methods: In this descriptive-analytical study, 219 patients with colon cancer were investigated. Data were analyzed through descriptive and univariate methods using R software. Kaplan-Meier survival analysis and log-rank test were used to evaluate the survival rate of the patients., Results: In the present study, 25% of patients were below 50 years of age. A family history of cancer was positive in 30% of the patients. According to the clinical symptoms of the patients, rectorrhagia was higher in patients with sigmoid tumor site, abdominal pain was higher in patients with transverse and ascending tumor sites, and anemia was higher in patients with ascending and caecum tumor sites (p< 0.05). The mean life expectancy of the patients was 53.71±2.07 months. Three-year, five-year and seven-year survival rates were 70, 49, and 37 %, respectively., Conclusion: Half of the patients were diagnosed at advanced stage and the mean survival time at advanced stage was approximately four years. One-third of the patients had local recurrence. It is recommended that patients refer to specialists at specified time intervals for timely diagnosis of the disease and prevention of its recurrence. Providing effective training for people in order for them to acquire more knowledge, and performing screening tests will lead to early diagnosis and lower mortality., (©2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases.)
- Published
- 2020
48. INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE.
- Author
-
Nobakht H, Mahmoudi T, Sabzikarian M, Tabaeian SP, Rezamand G, Asadi A, Farahani H, Dabiri R, Mansour-Ghanaei F, Maleki I, and Zali MR
- Subjects
- Adult, Aged, Case-Control Studies, Humans, Insulin genetics, Middle Aged, Polymorphism, Genetic, Genetic Predisposition to Disease, Non-alcoholic Fatty Liver Disease genetics, Receptor, Insulin genetics
- Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is an increasing global health concern defined by excessive hepatic fat content in the absence of excessive alcohol consumption., Objective: Given the pivotal role of insulin resistance in NAFLD, we hypothesized that insulin (INS) and insulin receptor (INSR) gene polymorphisms may be associated with NAFLD risk., Methods: A total of 312 subjects, including 153 cases with biopsy-proven NAFLD and 159 controls were enrolled in this case-control study. Four polymorphisms in INS (rs3842752, rs689) and INSR (rs1052371, rs1799817) genes were genotyped using PCR-RFLP method., Results: The cases with NAFLD were older and had higher BMI, systolic blood pressure, diastolic blood pressure, as well as higher serum levels of aspartate aminotransferase, alanine aminotransferase, and gamma glutamyl transferase than the controls (P<0.001). The "TT" genotype of INSR rs1799817 compared with "CC" genotype occurred more frequently in the controls than the cases with NAFLD and the difference remained significant after adjustment for confounding factors (P=0.018; OR=0.10, 95%CI=0.02-0.76). However, no significant difference was found for INS rs3842752, INS rs689, and INSR rs1052371 gene polymorphisms between the cases with NAFLD and the controls either before or after adjustment for the confounders., Conclusion: These findings corroborate the hypothesis that genetic polymorphisms related to insulin resistance play a role in NAFLD susceptibility. Specifically, the INSR rs1799817 "TT" genotype had a protective effect for NAFLD. However, our results remain to be validated in other studies.
- Published
- 2020
- Full Text
- View/download PDF
49. Helicobacter pylori eradication in the management of glaucoma.
- Author
-
Ala S, Maleki I, Sanjari Araghi A, Sahebnasagh A, and Shahraki A
- Abstract
Background: To investigate the possibility that the eradication of H pylori infection is associated with a reduction in the risk of glaucoma., Methods: Sixty-five successive patients with elevated intraocular pressure (IOP) or glaucoma were included in the study. Serum samples from all subjects were analyzed for the presence of H pylori - antibodies using ELISA. Forty patients with positive serologic test were included. Half of the patients enrolled into intervention group and the other half registered as control. Intervention arm was referred to the Gastroenterology Clinic for eradication of H pylori and evaluated for the effect of H pylori regimen eradication on IOP and glaucoma over 2 months of follow-up. The age-matched controls did not receive treatment. Urea breath test was applied to confirm eradication., Results: There was a significant (p=0.005) reduction in IOP after complete eradication in the intervention group. This value was not significant in control patients (p=0.08). The mean IOP before treatment of glaucoma in the control group was 23.60±2.37 mmHg and after treatment with anti-glaucoma drugs was 14.25±1.48 mmHg on the onset of study, and 13.55±2.01 mmHg after follow up. The mean IOP before treatment of glaucoma in the intervention group was 24.55±3.6 mmHg and after treatment with anti-glaucoma drugs was 15.15±1.8 mmHg, and 14.3±1.6 mmHg after the eradication of H pylori with a drug regimen. However, after the treatment of glaucoma in all patients, the overall comparison of mean IOP differences showed no statistical difference (P=0.65)., Conclusion: H pylori eradication therapy may have a positive effect on the management of glaucoma.
- Published
- 2020
- Full Text
- View/download PDF
50. Achieving an Ultrahigh Power Factor in Sb 2 Te 2 Se Monolayers via Valence Band Convergence.
- Author
-
Diznab MR, Maleki I, Vaez Allaei SM, Xia Y, and Naghavi SS
- Abstract
An efficient approach to improve the thermoelectric performance of materials is to converge their electronic bands, which is known as band engineering. In this regard, lots of effort has been made to further improve the thermoelectric efficiency of bulk and exfoliated monolayers of Bi
2 Te3 and Sb2 Te3 . However, ultrahigh band degeneracy and thus significant improvement of the power factor have not yet been realized in these materials. Using first-principles methods, we demonstrate that the valley degeneracy of Bi2 Te3 and Sb2 Te3 can be largely improved upon substitution of the middle-layer Te atoms with the more electronegative S or Se atoms. Our detailed analysis reveals that in this family of materials, two out of four possible valence band valleys merely depend on the electronegativity of the middle-layer chalcogen atoms, which makes the independent modulation of the valleys' position feasible. As such, band alignment of Bi2 Te3 and Sb2 Te3 largely improves upon substitution of the middle-layer Te atoms with more electronegative, yet chemically similar, S and Se ones. A superior valence band alignment is attained in Sb2 Te2 Se monolayers where three out of four possible valleys are well aligned, resulting in a giant band degeneracy of 18 that holds the record among all thermoelectric materials. As a result, an outstanding power factor for the hole-doped monolayers is achieved, indicating a highly efficient p-type thermoelectric material.- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.